Cardiol Therapeutics (CRDL) Short Interest Ratio & Short Volume → Missed NVDA? Buy this AI stock NOW (From Chaikin Analytics) (Ad) Free CRDL Stock Alerts $2.14 -0.07 (-3.17%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Cardiol Therapeutics Short Interest DataCurrent Short Volume328,100 sharesPrevious Short Volume275,200 sharesChange Vs. Previous Month+19.22%Dollar Volume Sold Short$659,481.00Short Interest Ratio / Days to Cover0.8Last Record DateApril 30, 2024Outstanding Shares68,284,000 sharesFloat Size65,040,000 sharesShort Percent of Float0.50%Today's Trading Volume320,409 sharesAverage Trading Volume324,726 sharesToday's Volume Vs. Average99% Short Selling Cardiol Therapeutics ? Sign up to receive the latest short interest report for Cardiol Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCRDL Short Interest Over TimeCRDL Days to Cover Over TimeCRDL Percentage of Float Shorted Over Time Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. Cardiol Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024328,100 shares $659,481.00 +19.2%0.5%0.8 $2.01 4/15/2024275,200 shares $492,608.00 -15.7%0.4%0.7 $1.79 3/31/2024326,600 shares $591,146.00 +19.6%0.5%0.8 $1.81 3/15/2024273,000 shares $414,960.00 -24.4%0.4%0.8 $1.52 2/29/2024361,100 shares $743,866.00 +108.1%0.6%1.1 $2.06 2/15/2024173,500 shares $256,780.00 +16.6%0.3%0.6 $1.48 Get the Latest News and Ratings for CRDL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024148,800 shares $181,536.00 +24.4%0.2%0.9 $1.22 1/15/2024119,600 shares $124,384.00 -9.1%0.2%0.8 $1.04 12/31/2023131,500 shares $110,880.80 -31.4%0.2%0.7 $0.84 12/15/2023191,800 shares $165,926.18 -14.7%0.3%0.9 $0.87 11/30/2023224,800 shares $206,029.20 -11.9%0.4%1 $0.92 11/15/2023255,200 shares $214,368.00 -17.5%0.4%1.2 $0.84 10/31/2023309,500 shares $256,885.00 -4.8%0.5%1.4 $0.83 10/15/2023325,100 shares $266,582.00 +32.1%0.5%1.2 $0.82 9/30/2023246,100 shares $220,259.50 +132.0%0.4%1.2 $0.90 9/15/2023106,100 shares $103,447.50 +46.6%0.2%0.6 $0.98 8/31/202372,400 shares $79,640.00 -49.2%0.1%0.4 $1.10 8/15/2023142,400 shares $134,482.56 +8.5%0.2%0.8 $0.94 7/31/2023131,200 shares $141,696.00 +49.3%0.2%0.7 $1.08 7/15/202387,900 shares $71,541.81 +3.8%0.1%0.7 $0.81 6/30/202384,700 shares $75,383.00 -26.7%0.1%0.6 $0.89 6/15/2023115,500 shares $91,533.75 -23.8%0.2%0.8 $0.79 5/31/2023151,500 shares $102,126.15 +1.3%0.3%1.3 $0.67 5/15/2023149,600 shares $82,280.00 +18.8%0.2%1.5 $0.55 4/30/2023125,900 shares $78,007.64 -21.1%0.2%1.1 $0.62 4/15/2023159,500 shares $82,541.25 -12.9%0.3%1.5 $0.52 3/31/2023183,100 shares $89,224.63 +8.9%0.3%1.8 $0.49 3/15/2023168,100 shares $82,369.00 +8.3%0.3%1.7 $0.49 2/28/2023155,200 shares $82,318.08 -41.3%0.3%1.3 $0.53 2/15/2023264,500 shares $150,765.00 -10.0%0.5%2.2 $0.57 1/31/2023293,800 shares $206,923.34 +8.9%0.5%2.3 $0.70 1/15/2023269,800 shares $217,350.88 +6.7%0.5%1.9 $0.81 12/30/2022252,900 shares $128,979.00 +11.0%0.4%1.5 $0.51 12/15/2022227,800 shares $152,626.00 -3.1%0.4%1.1 $0.67 11/30/2022235,100 shares $121,147.03 +10.3%0.4%1 $0.52 11/15/2022213,100 shares $135,169.33 -10.8%0.4%0.8 $0.63 10/31/2022239,000 shares $143,113.20 -33.0%0.4%0.9 $0.60 10/15/2022356,900 shares $232,698.80 -29.6%0.6%1.4 $0.65 9/30/2022506,600 shares $521,798.00 +2.2%0.9%2.2 $1.03 9/15/2022495,800 shares $609,834.00 +3.1%0.9%2.6 $1.23Collapse of the Petrodollar (Ad)The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar. For one main reason.In answer to this issue, we have released a Special Report to the public. CRDL Short Interest - Frequently Asked Questions What is Cardiol Therapeutics' current short interest? Short interest is the volume of Cardiol Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 328,100 shares of CRDL short. 0.50% of Cardiol Therapeutics' shares are currently sold short. Learn More on Cardiol Therapeutics' current short interest. What is a good short interest ratio for Cardiol Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRDL shares currently have a short interest ratio of 1.0. Learn More on Cardiol Therapeutics's short interest ratio. Which institutional investors are shorting Cardiol Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cardiol Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Cardiol Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.50% of Cardiol Therapeutics' floating shares are currently sold short. Is Cardiol Therapeutics' short interest increasing or decreasing? Cardiol Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 328,100 shares, an increase of 19.2% from the previous total of 275,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cardiol Therapeutics' float size? Cardiol Therapeutics currently has issued a total of 68,284,000 shares. Some of Cardiol Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cardiol Therapeutics currently has a public float of 65,040,000 shares. How does Cardiol Therapeutics' short interest compare to its competitors? 0.50% of Cardiol Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Cardiol Therapeutics: Molecular Partners AG (0.15%), Vaxart, Inc. (10.44%), DBV Technologies S.A. (0.28%), Scilex Holding (8.38%), Cardiff Oncology, Inc. (9.88%), BioAtla, Inc. (11.08%), Vigil Neuroscience, Inc. (4.61%), Omega Therapeutics, Inc. (22.04%), aTyr Pharma, Inc. (0.92%), Sangamo Therapeutics, Inc. (6.92%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Cardiol Therapeutics stock? Short selling CRDL is an investing strategy that aims to generate trading profit from Cardiol Therapeutics as its price is falling. CRDL shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cardiol Therapeutics? A short squeeze for Cardiol Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CRDL, which in turn drives the price of the stock up even further. How often is Cardiol Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRDL, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Molecular Partners Short Interest Vaxart Short Interest DBV Technologies Short Interest Scilex Short Interest Cardiff Oncology Short Interest BioAtla Short Interest Vigil Neuroscience Short Interest Omega Therapeutics Short Interest aTyr Pharma Short Interest Sangamo Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CRDL) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCollapse of the Petrodollar Colonial Metals[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICMissed NVDA? Buy this AI stock NOWChaikin AnalyticsYou need to know these two things about AI stocks ASAP…InvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press